Get More Information on Near-infrared Imaging Market - Request Sample Report
The Near-infrared Imaging Market size was estimated at USD 2.13 billion in 2023 and is expected to reach USD 3.03 billion by 2032 with a growing CAGR of 4% during the forecast period of 2024-2032.
The process of non-invasively measuring the oxygenation and hemoglobin content in muscles, the brain, and other tissues is known as near infrared imaging, also known as near infrared spectroscopy. Due to its non-invasive nature, which enables repeated use of this technology on the patient without any side effects or injury, near infrared diagnostic imaging is preferable to a number of other radio-imaging techniques currently in usage.
The use of visualization tools to execute the surgery has increased with the introduction of surgical treatments. Due to the growing number of chronic diseases brought on by stress, work pressure, poor eating habits, sedentary lifestyles, chemical exposure, and hereditary, many people have opted to undergo microsurgery on a big scale. The benefits of doing surgery on a medical problem at the right time are also raising public awareness, which is increasing the demand for surgical treatments and, in turn, the adoption rate of near infrared imaging. A survey from the American Society of Plastic Surgeons (ASPS) estimates that around 17.2 billion US dollars would be spent on cosmetic operations in the U.S. in 2022. During the projected period, these factors are anticipated to have a favorable effect on the market. So, over the course of the projection period, the market for near infrared imaging is anticipated to benefit from the increase in surgical procedures.
DRIVERS
Increasing count of surgical procedures
The occurrence and incidence of several diseases, including cancer, cardiovascular diseases, neurovascular disorders, and gastrointestinal diseases, are rising globally, contributing to an increase in surgical procedures. The rise in surgical treatments is also being fueled by trauma cases and surgical cosmetic procedures.
RESTRAIN
High cost of operation and high capital
The high cost of Near-infrared Imaging system acquisition and maintenance may restrict their utilization in healthcare environments. With an initial capital cost of between a few hundred thousand and more than a million dollars, NIR systems might be prohibitively expensive for hospitals and medical facilities with tight budgets. In addition, NIR systems necessitate continuous calibration, repair, and maintenance, as well as trained staff to operate and interpret the data, resulting in extra continuing expenditures that can be sizable and pile up over time. NIR systems are an expensive investment for many healthcare providers because of these issues.
OPPORTUNITY
Use of blockchain in imaging
Imaging is only one of several sectors that blockchain technology has the ability to transform. Data integrity, security, provenance, and decentralized storage are just a few advantages that using blockchain in imaging can bring. Through a tamper-proof and visible ledger, it can guarantee the authenticity and origin of images, making it useful for applications like medical imaging, art authentication, and copyright protection. Blockchain also makes it possible for decentralized storage and sharing, which lowers dependency on centralized servers and improves accessibility. While enhancing the security and privacy of medical imaging data, it can also make licensing and royalty monitoring for image usage simpler. In conclusion, blockchain has the potential to transform the imaging sector by bringing trust, transparency, and efficiency to a variety of applications.
CHALLENGES
Hospital budget cuts
Several healthcare providers have allied themselves with group buying organizations (GPOs), integrated health networks (IHNs), and integrated delivery networks (IDNs) in response to growing government pressure to lower healthcare costs. In order to negotiate a fair price with the suppliers and makers of medical devices, these groups pool the purchasing power of their members. For large-scale acquisitions of imaging devices, GPOs, IHNs, and IDNs engage in intense haggling.
The devastation of medical infrastructure such hospitals and clinics during the Russia-Ukraine war has had a significant negative impact on the health sector. Due to storage space restrictions and the expense of maintaining a significant inventory, the majority of hospitals rarely have supplies of medications and consumables that last longer than a few days. The supplies of bandages, blood, and medicines that are required to treat battle casualties are particularly low in these inventories. Given that surgical care has been compromised by hacking, it will be incredibly challenging to offer in Ukraine and challenging to determine the entire degree of the disruption to the health system.
By Product
Devices
Reagents
In 2023, reagents segment is expected to dominate the near-infrared imaging market share of around 56.8% growth rate during the forecast period due to its offer high sensitivity and precise detection in biological systems, have significant benefits over conventional visible light dyes. Indocyanine Green (ICG) and other reagents are subcategories of reagents. Due to the advantages provided by ICG, the reagents segment is anticipated to increase significantly during the projection period. Angiographic images in real time are provided using indocyanine green during brain tumor or vascular surgery. Additionally, spine surgery is using it more and more. ICG's advantages and expanding applications are hence the segment's main drivers.
By Application
Cancer Surgeries
Gastrointestinal Surgeries
Preclinical Imaging
Cardiovascular Surgeries
Plastic/Reconstructive Surgeries
In 2023, Preclinical Imaging segment is expected to dominate the near-infrared imaging market share of around 35.1% growth rate during the forecast period owing to the rising prevalence of cancer on a global scale. For example, according to International Agency for Research on Cancer in 2022, there were about 22,874,582 new cancer cases globally, the same source states that the number is expected to reach 50,550,287 by 2025.
By End User
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Research Laboratories
In 2023, Hospitals and Clinics segment is expected to dominate the near-infrared imaging market share of 45.6% during the forecast period owing to the more cancer patients are being admitted to hospitals, clinics, and other reputable healthcare institutions in affluent nations. In order to identify bedsores and avoid surgical mistakes, near infrared technology is frequently employed in hospitals and clinics.
REGIONAL ANALYSES
North America held a significant market share of 40.5% in 2023 and is likely to maintain its dominance during the forecast period due to the fast uptake of technologically improved medical gadgets, high consumer disposable income, and diagnostic method. Additionally, a significant increase in cancer cases reported in the nation is anticipated to strengthen the U.S. market. According to the International Agency for Research on Cancer, the United States saw an estimated 2,381,787 new cases of cancer in 2022. Also, the country's increase in reconstructive and cosmetic procedures due to higher spending and growing awareness of early diagnosis is anticipated to generate significant growth potential.
Asia-Pacific is witness to increase at the highest rate during the forecast period due to the Asia Pacific region has a large population base and a low per capita income, which has increased the need for accessible options for healthcare. International businesses are eager to invest in growing nations like South Korea, Japan, India, and more. Consequently, a lot of industry participants are forming strategic partnerships with regional players. The market for near infrared imaging is expected to grow as a result.
Get Customized Report as per Your Business Requirement - Request For Customized Report
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
The major players are Quest Medical Imaging B.V., Stryker, KARL STORZ SE & Co. KG, Olympus, Hamamatsu Photonics K.K, Mizuho Medical Co, Ltd., Shimadzu Corporation, Leica Microsystems, Medtronic (Visionsense), PerkinElmer, Inc., Carl Zeiss Meditec, Fluoptics, and Others.
KARL STORZ, in January 2021, the development in endoscopic imaging was announced by KARL STORZ with the introduction of the IMAGE1 S Rubina multimode viewing system. With the aid of indocyanine green dye, near-infrared light, and (NIR/ICG), this technique combines cutting-edge 4K resolution with outstanding fluorescence-guided imaging.
| Report Attributes | Details |
| Market Size in 2023 | US$ 2.13 Billion |
| Market Size by 2032 | US$ 3.03 Billion |
| CAGR | CAGR of 4% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Devices, Reagents) • By Application (Cancer Surgeries, Gastrointestinal Surgeries, Preclinical Imaging, Cardiovascular Surgeries, Plastic/Reconstructive Surgeries) • By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Research Laboratories) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Quest Medical Imaging B.V., Stryker, KARL STORZ SE & Co. KG, Olympus, Hamamatsu Photonics K.K, Mizuho Medical Co, Ltd., Shimadzu Corporation, Leica Microsystems, Medtronic (Visionsense), PerkinElmer, Inc., Carl Zeiss Meditec, Fluoptics |
| Key Drivers | • Increasing count of surgical procedures |
| Market Opportunity | • Use of blockchain in imaging |
Ans: The Near-infrared Imaging Market is expected to grow at 4% CAGR from 2024 to 2032.
Ans: According to our analysis, the Near-infrared Imaging Market is anticipated to reach USD 3.03 billion By 2032.
Ans: The leading participants are Quest Medical Imaging B.V., Stryker, KARL STORZ SE & Co. KG, Olympus, Hamamatsu Photonics K.K, Mizuho Medical Co, Ltd., Shimadzu Corporation, Leica Microsystems, Medtronic (Visionsense), PerkinElmer, Inc., Carl Zeiss Meditec, Fluoptics, and Others.
Ans: Factors such as the increasing count of surgical procedures and emerging demand in gastrointestinal endoscopes and minimally invasive treatment.
Ans: Yes, you may request customization based on your company's needs.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Near-infrared Imaging Market, By Product
8.1 Devices
8.2 Reagents
9. Near-infrared Imaging Market, By Application
9.1 Cancer Surgeries
9.2 Gastrointestinal Surgeries
9.3 Preclinical Imaging
9.4 Cardiovascular Surgeries
9.5 Plastic/Reconstructive Surgeries
10. Near-infrared Imaging Market, By End User
10.1 Hospitals & Clinics
10.2 Pharmaceutical & Biotechnology Companies
10.3 Research Laboratories
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Near-infrared Imaging Market by Country
11.2.2 North America Near-infrared Imaging Market by Product
11.2.3 North America Near-infrared Imaging Market by Application
11.2.4 North America Near-infrared Imaging Market by End User
11.2.5 USA
11.2.5.1 USA Near-infrared Imaging Market by Product
11.2.5.2 USA Near-infrared Imaging Market by Application
11.2.5.3 USA Near-infrared Imaging Market by End User
11.2.6 Canada
11.2.6.1 Canada Near-infrared Imaging Market by Product
11.2.6.2 Canada Near-infrared Imaging Market by Application
11.2.6.3 Canada Near-infrared Imaging Market by End User
11.2.7 Mexico
11.2.7.1 Mexico Near-infrared Imaging Market by Product
11.2.7.2 Mexico Near-infrared Imaging Market by Application
11.2.7.3 Mexico Near-infrared Imaging Market by End User
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Near-infrared Imaging Market by Country
11.3.1.2 Eastern Europe Near-infrared Imaging Market by Product
11.3.1.3 Eastern Europe Near-infrared Imaging Market by Application
11.3.1.4 Eastern Europe Near-infrared Imaging Market by End User
11.3.1.5 Poland
11.3.1.5.1 Poland Near-infrared Imaging Market by Product
11.3.1.5.2 Poland Near-infrared Imaging Market by Application
11.3.1.5.3 Poland Near-infrared Imaging Market by End User
11.3.1.6 Romania
11.3.1.6.1 Romania Near-infrared Imaging Market by Product
11.3.1.6.2 Romania Near-infrared Imaging Market by Application
11.3.1.6.3 Romania Near-infrared Imaging Market by End User
11.3.1.7 Turkey
11.3.1.7.1 Turkey Near-infrared Imaging Market by Product
11.3.1.7.2 Turkey Near-infrared Imaging Market by Application
11.3.1.7.3 Turkey Near-infrared Imaging Market by End User
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Near-infrared Imaging Market by Product
11.3.1.8.2 Rest of Eastern Europe Near-infrared Imaging Market by Application
11.3.1.8.3 Rest of Eastern Europe Near-infrared Imaging Market by End User
11.3.2 Western Europe
11.3.2.1 Western Europe Near-infrared Imaging Market by Product
11.3.2.2 Western Europe Near-infrared Imaging Market by Application
11.3.2.3 Western Europe Near-infrared Imaging Market by End User
11.3.2.4 Germany
11.3.2.4.1 Germany Near-infrared Imaging Market by Product
11.3.2.4.2 Germany Near-infrared Imaging Market by Application
11.3.2.4.3 Germany Near-infrared Imaging Market by End User
11.3.2.5 France
11.3.2.5.1 France Near-infrared Imaging Market by Product
11.3.2.5.2 France Near-infrared Imaging Market by Application
11.3.2.5.3 France Near-infrared Imaging Market by End User
11.3.2.6 UK
11.3.2.6.1 UK Near-infrared Imaging Market by Product
11.3.2.6.2 UK Near-infrared Imaging Market by Application
11.3.2.6.3 UK Near-infrared Imaging Market by End User
11.3.2.7 Italy
11.3.2.7.1 Italy Near-infrared Imaging Market by Product
11.3.2.7.2 Italy Near-infrared Imaging Market by Application
11.3.2.7.3 Italy Near-infrared Imaging Market by End User
11.3.2.8 Spain
11.3.2.8.1 Spain Near-infrared Imaging Market by Product
11.3.2.8.2 Spain Near-infrared Imaging Market by Application
11.3.2.8.3 Spain Near-infrared Imaging Market by End User
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands Near-infrared Imaging Market by Product
11.3.2.9.2 Netherlands Near-infrared Imaging Market by Application
11.3.2.9.3 Netherlands Near-infrared Imaging Market by End User
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland Near-infrared Imaging Market by Product
11.3.2.10.2 Switzerland Near-infrared Imaging Market by Application
11.3.2.10.3 Switzerland Near-infrared Imaging Market by End User
11.3.2.11 Austria
11.3.2.11.1 Austria Near-infrared Imaging Market by Product
11.3.2.11.2 Austria Near-infrared Imaging Market by Application
11.3.2.11.3 Austria Near-infrared Imaging Market by End User
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe Near-infrared Imaging Market by Product
11.3.2.12.2 Rest of Western Europe Near-infrared Imaging Market by Application
11.3.2.12.3 Rest of Western Europe Near-infrared Imaging Market by End User
11.4 Asia-Pacific
11.4.1 Asia-Pacific Near-infrared Imaging Market by Country
11.4.2 Asia-Pacific Near-infrared Imaging Market by Product
11.4.3 Asia-Pacific Near-infrared Imaging Market by Application
11.4.4 Asia-Pacific Near-infrared Imaging Market by End User
11.4.5 China
11.4.5.1 China Near-infrared Imaging Market by Product
11.4.5.2 China Near-infrared Imaging Market by Application
11.4.5.3 China Near-infrared Imaging Market by End User
11.4.6 India
11.4.6.1 India Near-infrared Imaging Market by Product
11.4.6.2 India Near-infrared Imaging Market by Application
11.4.6.3 India Near-infrared Imaging Market by End User
11.4.7 Japan
11.4.7.1 Japan Near-infrared Imaging Market by Product
11.4.7.2 Japan Near-infrared Imaging Market by Application
11.4.7.3 Japan Near-infrared Imaging Market by End User
11.4.8 South Korea
11.4.8.1 South Korea Near-infrared Imaging Market by Product
11.4.8.2 South Korea Near-infrared Imaging Market by Application
11.4.8.3 South Korea Near-infrared Imaging Market by End User
11.4.9 Vietnam
11.4.9.1 Vietnam Near-infrared Imaging Market by Product
11.4.9.2 Vietnam Near-infrared Imaging Market by Application
11.4.9.3 Vietnam Near-infrared Imaging Market by End User
11.4.10 Singapore
11.4.10.1 Singapore Near-infrared Imaging Market by Product
11.4.10.2 Singapore Near-infrared Imaging Market by Application
11.4.10.3 Singapore Near-infrared Imaging Market by End User
11.4.11 Australia
11.4.11.1 Australia Near-infrared Imaging Market by Product
11.4.11.2 Australia Near-infrared Imaging Market by Application
11.4.11.3 Australia Near-infrared Imaging Market by End User
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Near-infrared Imaging Market by Product
11.4.12.2 Rest of Asia-Pacific Near-infrared Imaging Market by Application
11.4.12.3 Rest of Asia-Pacific Near-infrared Imaging Market by End User
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Near-infrared Imaging Market by Country
11.5.1.2 Middle East Near-infrared Imaging Market by Product
11.5.1.3 Middle East Near-infrared Imaging Market by Application
11.5.1.4 Middle East Near-infrared Imaging Market by End User
11.5.1.5 UAE
11.5.1.5.1 UAE Near-infrared Imaging Market by Product
11.5.1.5.2 UAE Near-infrared Imaging Market by Application
11.5.1.5.3 UAE Near-infrared Imaging Market by End User
11.5.1.6 Egypt
11.5.1.6.1 Egypt Near-infrared Imaging Market by Product
11.5.1.6.2 Egypt Near-infrared Imaging Market by Application
11.5.1.6.3 Egypt Near-infrared Imaging Market by End User
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Near-infrared Imaging Market by Product
11.5.1.7.2 Saudi Arabia Near-infrared Imaging Market by Application
11.5.1.7.3 Saudi Arabia Near-infrared Imaging Market by End User
11.5.1.8 Qatar
11.5.1.8.1 Qatar Near-infrared Imaging Market by Product
11.5.1.8.2 Qatar Near-infrared Imaging Market by Application
11.5.1.8.3 Qatar Near-infrared Imaging Market by End User
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Near-infrared Imaging Market by Product
11.5.1.9.2 Rest of Middle East Near-infrared Imaging Market by Application
11.5.1.9.3 Rest of Middle East Near-infrared Imaging Market by End User
11.5.2 Africa
11.5.2.1 Africa Near-infrared Imaging Market by Country
11.5.2.2 Africa Near-infrared Imaging Market by Product
11.5.2.3 Africa Near-infrared Imaging Market by Application
11.5.2.4 Africa Near-infrared Imaging Market by End User
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Near-infrared Imaging Market by Product
11.5.2.5.2 Nigeria Near-infrared Imaging Market by Application
11.5.2.5.3 Nigeria Near-infrared Imaging Market by End User
11.5.2.6 South Africa
11.5.2.6.1 South Africa Near-infrared Imaging Market by Product
11.5.2.6.2 South Africa Near-infrared Imaging Market by Application
11.5.2.6.3 South Africa Near-infrared Imaging Market by End User
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Near-infrared Imaging Market by Product
11.5.2.7.2 Rest of Africa Near-infrared Imaging Market by Application
11.5.2.7.3 Rest of Africa Near-infrared Imaging Market by End User
11.6 Latin America
11.6.1 Latin America Near-infrared Imaging Market by Country
11.6.2 Latin America Near-infrared Imaging Market by Product
11.6.3 Latin America Near-infrared Imaging Market by Application
11.6.4 Latin America Near-infrared Imaging Market by End User
11.6.5 Brazil
11.6.5.1 Brazil Near-infrared Imaging Market by Product
11.6.5.2 Brazil Near-infrared Imaging Market by Application
11.6.5.3 Brazil Near-infrared Imaging Market by End User
11.6.6 Argentina
11.6.6.1 Argentina Near-infrared Imaging Market by Product
11.6.6.2 Argentina Near-infrared Imaging Market by Application
11.6.6.3 Argentina Near-infrared Imaging Market by End User
11.6.7 Colombia
11.6.7.1 Colombia Near-infrared Imaging Market by Product
11.6.7.2 Colombia Near-infrared Imaging Market by Application
11.6.7.3 Colombia Near-infrared Imaging Market by End User
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Near-infrared Imaging Market by Product
11.6.8.2 Rest of Latin America Near-infrared Imaging Market by Application
11.6.8.3 Rest of Latin America Near-infrared Imaging Market by End User
12. Company Profile
12.1 Quest Medical Imaging B.V.
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Stryker
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 KARL STORZ SE & Co. KG
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Olympus
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Hamamatsu Photonics K.K
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Mizuho Medical Co, Ltd.
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Shimadzu Corporation
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Leica Microsystems
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Medtronic (Visionsense)
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 PerkinElmer, Inc.
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
12.11 Carl Zeiss Meditec
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Products/ Services Offered
12.11.4 SWOT Analysis
12.11.5 The SNS View
12.12 Fluoptics
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Products/ Services Offered
12.11.4 SWOT Analysis
12.11.5 The SNS View
12.13 Others
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Products/ Services Offered
12.11.4 SWOT Analysis
12.11.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. USE Cases and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Non-Invasive Fat Reduction Market Size was valued at USD 1.39 billion in 2023 and is expected to reach USD 4.67 billion by 2031, and grow at a CAGR of 16.3% over the forecast period 2024-2031.
The Medical Equipment Rental Market was valued at USD 58.57 Billion in 2023 and is expected to reach USD 97.69 billion by 2032 and grow at a CAGR of 5.85% over the forecast period 2024-2032.
The Portable Ultrasound Market size was USD 2678.60 Million in 2023 and is expected to reach USD 7481.55 Million by 2031 and grow at a CAGR of 13.7% over the forecast period of 2024-2031.
Hepatitis Testing Market was valued at USD 3.53 billion in 2023 and is expected to reach USD 5.75 billion by 2032, growing at a CAGR of 5.62% from 2024-2032
The Omega 3 supplements market was valued USD 7 billion in 2023 and is estimated to reach USD 15 billion by 2032. From 2024 to 2032 & grow at a CAGR of 8.8%.
The Serum-free Media Market size was estimated at USD 1.70 billion in 2023 and is expected to reach USD 4.76 billion by 2032 at a CAGR of 12.16% during the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
